NASDAQ:BIIB - Biogen Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$353.03 +4.55 (+1.31 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$348.48
Today's Range$346.10 - $353.20
52-Week Range$249.17 - $370.57
Volume1.46 million shs
Average Volume1.75 million shs
Market Capitalization$73.53 billion
P/E Ratio16.15
Dividend YieldN/A

Analyst Ratings

Biogen (NASDAQ:BIIB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
29 Wall Street analysts have issued ratings and price targets for Biogen in the last 12 months. Their average twelve-month price target is $361.3019, suggesting that the stock has a possible upside of 2.34%. The high price target for BIIB is $425.00 and the low price target for BIIB is $262.15. There are currently 9 hold ratings and 20 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.692.722.692.76
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
20 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
21 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
20 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
20 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $361.3019$353.4130$367.2222$354.00
Price Target Upside: 2.34% upside18.34% upside38.71% upside4.47% upside

Biogen (NASDAQ:BIIB) Consensus Price Target History

Price Target History for Biogen (NASDAQ:BIIB)

Biogen (NASDAQ:BIIB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/13/2018Morgan StanleyLower Price TargetOverweight$369.00 ➝ $366.00LowView Rating Details
7/11/2018Piper Jaffray CompaniesBoost Price TargetOverweight$365.00LowView Rating Details
7/10/2018Royal Bank of CanadaBoost Price TargetMarket Perform$349.00MediumView Rating Details
7/10/2018Robert W. BairdDowngradeOutperform ➝ Neutral$323.00MediumView Rating Details
7/9/2018UBS GroupDowngradeBuy ➝ HoldMediumView Rating Details
7/9/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Hold$400.00MediumView Rating Details
7/9/2018HC WainwrightReiterated RatingBuyMediumView Rating Details
7/8/2018OppenheimerSet Price TargetBuy$375.00 ➝ $400.00MediumView Rating Details
7/6/2018NomuraReiterated RatingBuy$420.00HighView Rating Details
7/6/2018JPMorgan Chase & Co.Reiterated RatingBuyHighView Rating Details
7/6/2018Canaccord GenuitySet Price TargetBuy$335.00HighView Rating Details
7/6/2018CitigroupUpgradeNeutral ➝ Buy$371.00HighView Rating Details
7/6/2018MizuhoSet Price TargetBuy$423.00HighView Rating Details
4/26/2018Cantor FitzgeraldReiterated RatingNeutralMediumView Rating Details
4/25/2018Leerink SwannSet Price TargetMarket Perform ➝ Hold$365.00 ➝ $325.00HighView Rating Details
4/25/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$388.00 ➝ $262.15HighView Rating Details
4/24/2018Stifel NicolausSet Price TargetBuy$425.00HighView Rating Details
4/24/2018GuggenheimSet Price TargetBuy$385.00HighView Rating Details
4/24/2018Credit Suisse GroupSet Price TargetBuy$384.00HighView Rating Details
4/24/2018SunTrust BanksSet Price TargetBuy$321.00HighView Rating Details
4/24/2018CowenReiterated RatingBuy$408.00HighView Rating Details
4/10/2018Sanford C. BernsteinSet Price TargetBuy$318.00MediumView Rating Details
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$395.00 ➝ $295.00HighView Rating Details
3/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$403.00 ➝ $393.00LowView Rating Details
2/16/2018ArgusDowngradeBuy ➝ HoldMediumView Rating Details
2/15/2018William BlairReiterated RatingBuyLowView Rating Details
1/26/2018Deutsche BankReiterated RatingBuy$373.00LowView Rating Details
10/18/2017Bank of AmericaBoost Price TargetBuy$358.00 ➝ $365.00N/AView Rating Details
9/21/2017Raymond JamesDowngradeStrong-Buy ➝ Market Perform$244.28 ➝ $319.00LowView Rating Details
3/1/2017InstinetInitiated CoverageBuy ➝ Buy$223.03 ➝ $345.00N/AView Rating Details
8/2/2016Standpoint ResearchDowngradeBuy ➝ HoldN/AView Rating Details
(Data available from 7/16/2016 forward)
This page was last updated on 7/16/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.